Logo image
Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model
Journal article   Open access   Peer reviewed

Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model

Emilie A Bard-Chapeau, Anh-Tuan Nguyen, Alistair G Rust, Ahmed Sayadi, Philip Lee, Belinda Q Chua, Lee-Sun New, Johann de Jong, Jerrold M Ward, Christopher Ky Chin, …
Nature genetics, Vol.46(1), pp.24-32
01/2014
DOI: 10.1038/ng.2847
PMCID: PMC4131144
PMID: 24316982
url
http://doi.org/10.1038/ng.2847View
Open Access

Abstract

The most common risk factor for developing hepatocellular carcinoma (HCC) is chronic infection with hepatitis B virus (HBV). To better understand the evolutionary forces driving HCC, we performed a near-saturating transposon mutagenesis screen in a mouse HBV model of HCC. This screen identified 21 candidate early stage drivers and a very large number (2,860) of candidate later stage drivers that were enriched for genes that are mutated, deregulated or functioning in signaling pathways important for human HCC, with a striking 1,199 genes being linked to cellular metabolic processes. Our study provides a comprehensive overview of the genetic landscape of HCC.
Mutagenesis Liver Neoplasms - virology Liver Neoplasms - genetics Humans Gene Expression Regulation, Neoplastic Mice, Transgenic Carcinoma, Hepatocellular - virology Metabolomics - methods DNA Transposable Elements Metabolic Networks and Pathways - genetics Animals Hepatitis B, Chronic - complications Carcinoma, Hepatocellular - genetics Liver Neoplasms - metabolism Pyruvic Acid - metabolism Mice Mutagenesis, Insertional Carcinoma, Hepatocellular - metabolism Disease Models, Animal

Details

Metrics

Logo image